Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis
We describe 27 children and adolescents <18 years of age who received bedaquiline during treatment for multidrug-resistant tuberculosis. We report good treatment responses and no cessation attributable to adverse effects. Bedaquiline could be considered for use with this age group for multidrug-r...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2017-10-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/23/10/17-0303_article |
| _version_ | 1828888747964366848 |
|---|---|
| author | Jay Achar Cathy Hewison Ana P. Cavalheiro Alena Skrahina Junia Cajazeiro Parpieva Nargiza Krzysztof Herboczek Assliddin S. Rajabov Jennifer Hughes Gabriella Ferlazzo James A. Seddon Philipp du Cros |
| author_facet | Jay Achar Cathy Hewison Ana P. Cavalheiro Alena Skrahina Junia Cajazeiro Parpieva Nargiza Krzysztof Herboczek Assliddin S. Rajabov Jennifer Hughes Gabriella Ferlazzo James A. Seddon Philipp du Cros |
| author_sort | Jay Achar |
| collection | DOAJ |
| description | We describe 27 children and adolescents <18 years of age who received bedaquiline during treatment for multidrug-resistant tuberculosis. We report good treatment responses and no cessation attributable to adverse effects. Bedaquiline could be considered for use with this age group for multidrug-resistant tuberculosis when treatment options are limited. |
| first_indexed | 2024-12-13T12:28:52Z |
| format | Article |
| id | doaj.art-544059b4ad5c40e8a553eb2fbb726833 |
| institution | Directory Open Access Journal |
| issn | 1080-6040 1080-6059 |
| language | English |
| last_indexed | 2024-12-13T12:28:52Z |
| publishDate | 2017-10-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj.art-544059b4ad5c40e8a553eb2fbb7268332022-12-21T23:46:08ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592017-10-0123101711171310.3201/eid2310.170303Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant TuberculosisJay AcharCathy HewisonAna P. CavalheiroAlena SkrahinaJunia CajazeiroParpieva NargizaKrzysztof HerboczekAssliddin S. RajabovJennifer HughesGabriella FerlazzoJames A. SeddonPhilipp du CrosWe describe 27 children and adolescents <18 years of age who received bedaquiline during treatment for multidrug-resistant tuberculosis. We report good treatment responses and no cessation attributable to adverse effects. Bedaquiline could be considered for use with this age group for multidrug-resistant tuberculosis when treatment options are limited.https://wwwnc.cdc.gov/eid/article/23/10/17-0303_articleMDR TBXDR TBpediatrictreatmentbedaquilinetuberculosis |
| spellingShingle | Jay Achar Cathy Hewison Ana P. Cavalheiro Alena Skrahina Junia Cajazeiro Parpieva Nargiza Krzysztof Herboczek Assliddin S. Rajabov Jennifer Hughes Gabriella Ferlazzo James A. Seddon Philipp du Cros Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis Emerging Infectious Diseases MDR TB XDR TB pediatric treatment bedaquiline tuberculosis |
| title | Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis |
| title_full | Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis |
| title_fullStr | Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis |
| title_full_unstemmed | Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis |
| title_short | Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis |
| title_sort | off label use of bedaquiline in children and adolescents with multidrug resistant tuberculosis |
| topic | MDR TB XDR TB pediatric treatment bedaquiline tuberculosis |
| url | https://wwwnc.cdc.gov/eid/article/23/10/17-0303_article |
| work_keys_str_mv | AT jayachar offlabeluseofbedaquilineinchildrenandadolescentswithmultidrugresistanttuberculosis AT cathyhewison offlabeluseofbedaquilineinchildrenandadolescentswithmultidrugresistanttuberculosis AT anapcavalheiro offlabeluseofbedaquilineinchildrenandadolescentswithmultidrugresistanttuberculosis AT alenaskrahina offlabeluseofbedaquilineinchildrenandadolescentswithmultidrugresistanttuberculosis AT juniacajazeiro offlabeluseofbedaquilineinchildrenandadolescentswithmultidrugresistanttuberculosis AT parpievanargiza offlabeluseofbedaquilineinchildrenandadolescentswithmultidrugresistanttuberculosis AT krzysztofherboczek offlabeluseofbedaquilineinchildrenandadolescentswithmultidrugresistanttuberculosis AT assliddinsrajabov offlabeluseofbedaquilineinchildrenandadolescentswithmultidrugresistanttuberculosis AT jenniferhughes offlabeluseofbedaquilineinchildrenandadolescentswithmultidrugresistanttuberculosis AT gabriellaferlazzo offlabeluseofbedaquilineinchildrenandadolescentswithmultidrugresistanttuberculosis AT jamesaseddon offlabeluseofbedaquilineinchildrenandadolescentswithmultidrugresistanttuberculosis AT philippducros offlabeluseofbedaquilineinchildrenandadolescentswithmultidrugresistanttuberculosis |